Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients

Diabetes Research and Clinical Practice

Volumn 51, Issue 2, 2001, Pages 97-105

  Bruttomesso, Daniela ^a   Fongher, Cristiano ^a   Silvestri, Barbara ^a   Barberio, Silvia ^a   Marescotti, Maria Cristina ^a   Iori, Elisabetta ^a   Valerio, Anna ^a   Crazzolara, Dalia ^a   Pianta, Alessandro ^a   Tiengo, Antonio ^a   Del Prato, Stefano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Continuous subcutaneous insulin infusion; Continuous subcutaneous octreotide infusion; Counterregulatory hormones; Insulin resistance; Type 1 diabetes

Indexed keywords

INSULIN; OCTREOTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE OXIDATION; HUMAN; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN SENSITIVITY; MALE;

ADULT; ALANINE; BLOOD GLUCOSE; CALORIMETRY, INDIRECT; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, NONESTERIFIED; GLUCAGON; HEMOGLOBIN A, GLYCOSYLATED; HORMONES; HUMAN GROWTH HORMONE; HUMANS; INFUSIONS, PARENTERAL; INSULIN; INSULIN INFUSION SYSTEMS; LACTATES; MALE; OCTREOTIDE;

EID: 0035130194     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00210-2     Document Type: Article

References (24)

1. Natural course of insulin resistance in type I diabetes
2. Insulin-mediated glucose disposal in type I diabetes: Evidence for insulin resistance
3. Insulin-counteracting hormones: Their impact on glucose metabolism
4. Hyperglucagonemia and insulin-mediated glucose metabolism
5. Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas
6. Metabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy
7. The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitus
8. Continuous subcutaneous octreotide infusion: Dose-response relationships between metabolic effects and octreotide clearance in patients with insulin-dependent (type 1) diabetes
9. Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus
10. Evaluation of insulin sensitivity in man
11. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus
12. The theoretical bases of indirect calorimetry: A review
13. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: Effect of glucagon infusion
14. Glucose kinetics. Tracer methods
15. Severe hypoglycemia as a short-term side-effect of the somatostatin analog SMS 201-995 in insulin-dependent diabetes mellitus
16. Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathy
17. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance
18. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps
19. Intravenous and subcutaneous administration of a long-acting somatostatin analogue: Effects on glucose metabolism and splanchnic haemodynamics in healthy subjects
20. The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis
21. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization
22. Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus
23. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: A model for stress-induced hyperglycemia